Correlation of the Growth Fraction, Nucleolar Organizer Region Counts and Epidermal Growth Factor Receptor with Histomorphological Prognostic Criteria in Breast Cancer

Indian Journal of Pathology and Microbiology

Volumn 40, Issue 1, 1997, Pages 3-10

  Gupta, G R ^a   Datta, B N ^a   Bose, S M ^a   Joshi, K ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Breast cancer; Epidermal growth factor receptor; Growth fraction; Nucleolar organiser region count; Prognostic factors

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; NUCLEAR PROTEIN;

ARTICLE; BREAST TUMOR; CELL COUNT; CELL DIVISION; FEMALE; HUMAN; IMMUNOLOGY; LYMPH NODE METASTASIS; PROGNOSIS;

BREAST NEOPLASMS; CELL COUNT; CELL DIVISION; FEMALE; HUMANS; LYMPHATIC METASTASIS; NUCLEAR PROTEINS; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 0030627914     PISSN: 03774929     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Gerdes J, Li L, Schlueter C: Immunobiochemical and molecular biologic characterization of the cell proliferation associated nuclear antigen that is defined by monoclonal antibody Ki67. Am J Pathol 138: 867-73, 1991.
2. Gerdes J, Duchrow M, Schlueter C: Molecular cloning of the human Ki67 gene (MK1-67). Anal Cell Pathol 4: 159 1992
3. Underwood JCE, Giri DD: Nucleolar organizer regions as diagnostic discrimi- nants for malignancy. J. Pathol 155: 95-6, 1988.
4. Walker RA: The histopathological evaluation of Nucleolar organizer regions proteins. Histopathology 12: 221-25, 1988.
5. Stoschek CM, King LE: Role of epidermal growth factor in carcinogenesis. Cancer Res 46: 1030-1033, 1986.
6. Stein H, Bonk A, Tolksdorf G, Lennert K, Rodt H, Gerdes J: Immun-ohistologic analysis of the organization of normal lymphoid tissue and non Hodgkin's lymphoma. J. Histochem Cytochem 28: 746-760, 1980.
7. Crocker J, Boldy DAR, Egan MJ: How should we count AgNORs? Proposals for a standardized approach. J Pathol 158: 185-88, 1989.
8. Elston CW, Ellis IO: Pathological prognostic factors in breast cancer: The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology 19: 403-10, 1991.
9. Fisher B, Slack NH: Number of Lymphnode examined and the prognosis of breast carcinoma. Surg Gynae Obstet 131: 79-88, 1970.
10. Joshi K, Mehtani VG, Mehrotra GC: The pathologic profile of invasive breast cancer. Factors intrinsic to the tumour. Indian J Cancer 20: 15-22, 1983.
11. Badwe RA, Gangawal S, Mitra I, Desai PB: Clinicopathological features and prognosis of breast cancer in different religious communities in India Indian J Cancer 27: 220-229, 1990.
12. Murthy L, Varma K: Incidence and relationship of sex chromatin with histological appearance of tumour in breast carcinoma. Indian J Pathol Microbiol 29: 159-65, 1986.
13. Barnard NJ, Hall PA, Lemoine NR, Kadar N: Proliferative index in breast carcinoma determined in-situ by Ki-67 immunostaining and its relationship to clinical and pathological variables. J Pathol 152: 287-95, 1987.
14. Crispino S, Brenna A, Colombo D, Flores B, D'Amico S: Ki67 labelling index in breast cancer. Tumour 75: 557-62, 1989.
15. Gasparini G, Dalfior S, Pozza F, Bevilacqua P: Correlation of growth fraction by Ki67 immunohistochemistry with histologic factors and hormone receptors in operable breast carcinoma. Breast Cancer Res Treat: 14: 329-36, 1989.
16. Stahl A: The nucleolus and chromosomes. In Jordan EG, Cullies CA, eds. The nucleolus. Cambridge University Press 1-24, 1982.
17. S. Jane Darton, Michael R Gray, John Grocker: Letters to editors. Another cautionary note on the use of PCNA and AgNORS as markers of proliferation. J Pathol 168: 87, 1992.
18. Ohre AK, Ohri SK, Herbert A, Royle G, Taylor I: The relationship between clinical staging, oestrogen receptor status and silver binding nucleolar organizer regions (AgNOR) in breast carcinoma. Eur J Surg Oncol 18: 103-7, 1992.
19. Sacks NP, Robertson JF, Ellis IO, Nicholson RI, Crocker J, Blarney RW: Silver Stained nucleolar organiser region counts are of no prognostic value in primary breast cancer. Eur J Surg Oncol 18: 98-102, 1992.
20. Dervan PA, Gilmartin LG, Loftus BM, Carney DW: Breast carcinoma kinetsics. Argyrophilic nucleolar organizer region (AgNOR) counts correlate with Ki67 scores. Am J Clin Pathol 92: 401-7, 1989.
21. Canepa M, Gambini C, Sementa AR, Borgiani L, Rovida S: Nucleolar organizer regions and Ki67 immunostaining in ductal breast cancer. A comparative study. Pathologica 82: 125-32, 1990.
22. Raymond WA, Anthony SYL: Nucleolar organizer regions relate to growth fractions in human breast carcinoma. Human Pathology 20: 741-46, 1989.
23. Hahn J, Linhart W, M'uller H, Renz S, Sohneider M: Histochemical and histomorphometric studies on growth fractions in human breast carcinoma. Verh Dtsch Ces Pathol 74: 262-7, 1990.
24. Gullick WJ, Lemoine NR: 'EGF Receptor' antibody 29.1.1 Letter to editor. J Pathol 162: 275, 1990.
25. J.G.M. Klijn, P.M.J.J. Berns, P. I. M. Schmitz, J.A. Foekens: The Clinical Significance of Epidermal Growth Factor Receptor (EGE-R) in Human Breast Cancer: A Review on 5232 Patients. Endocrine Rev 13: 3-16, 1993.
26. Mittra I: A meta-analysis of reported correlations between prognostic factors in breast cancer: does axillary lymph node metastasis represent biology or chronology? Eitr J Cancer 27: 1574-83, 1991.